MDMA and psilocybin have been granted breakthrough therapy status by the FDA, signaling a shift in the future of mental health treatment.
Clinical studies are underway. How we treat them moving forward matters.
From mushrooms to ecstasy, a renaissance in psychedelics research
Posted in biotech/medical, neuroscience